| SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor M Hoffmann, H Kleine-Weber, S Schroeder, N Krüger, T Herrler, ... cell 181 (2), 271-280. e8, 2020 | 22250 | 2020 |
| Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR VM Corman, O Landt, M Kaiser, R Molenkamp, A Meijer, DKW Chu, ... Eurosurveillance 25 (3), 2000045, 2020 | 8810 | 2020 |
| Virological assessment of hospitalized patients with COVID-2019 R Wölfel, VM Corman, W Guggemos, M Seilmaier, S Zange, MA Müller, ... Nature 581 (7809), 465-469, 2020 | 7974 | 2020 |
| Identification of a novel coronavirus in patients with severe acute respiratory syndrome C Drosten, S Günther, W Preiser, S Van Der Werf, HR Brodt, S Becker, ... New England journal of medicine 348 (20), 1967-1976, 2003 | 6612 | 2003 |
| Transmission of 2019-nCoV infection from an asymptomatic contact in Germany C Rothe, M Schunk, P Sothmann, G Bretzel, G Froeschl, C Wallrauch, ... New England journal of medicine 382 (10), 970-971, 2020 | 5551 | 2020 |
| The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China DS Hui, EI Azhar, TA Madani, F Ntoumi, R Kock, O Dar, G Ippolito, ... International journal of infectious diseases 91, 264-266, 2020 | 4232 | 2020 |
| The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 A Gorbalenya, S Baker, RS Baric, R de Groot, C Drosten, AA Gulyaeva, ... Nature microbiology 5 (4), 536-544, 2020 | 4182 | 2020 |
| Characterization of a novel coronavirus associated with severe acute respiratory syndrome PA Rota, MS Oberste, SS Monroe, WA Nix, R Campagnoli, JP Icenogle, ... science 300 (5624), 1394-1399, 2003 | 3519 | 2003 |
| Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors L Zhang, D Lin, X Sun, U Curth, C Drosten, L Sauerhering, S Becker, ... Science 368 (6489), 409-412, 2020 | 3346 | 2020 |
| Severe acute respiratory syndrome-related coronavirus: The species and its viruses–a statement of the Coronavirus Study Group AE Gorbalenya, SC Baker, RS Baric, RJ de Groot, C Drosten, ... BioRxiv, 2020 | 2605 | 2020 |
| Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC VS Raj, H Mou, SL Smits, DHW Dekkers, MA Müller, R Dijkman, D Muth, ... Nature 495 (7440), 251-254, 2013 | 2442 | 2013 |
| The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Nature microbiology 5 (4), 536-544, 2020 | 2041 | 2020 |
| Commentary: Middle east respiratory syndrome coronavirus (mers-cov): announcement of the coronavirus study group RJ De Groot, SC Baker, RS Baric, CS Brown, C Drosten, L Enjuanes, ... Journal of virology 87 (14), 7790-7792, 2013 | 1686 | 2013 |
| Severe acute respiratory syndrome coronavirus 2− specific antibody responses in coronavirus disease patients NMA Okba, MA Müller, W Li, C Wang, CH GeurtsvanKessel, VM Corman, ... Emerging infectious diseases 26 (7), 1478, 2020 | 1665 | 2020 |
| Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 J Meinhardt, J Radke, C Dittmayer, J Franz, C Thomas, R Mothes, M Laue, ... Nature neuroscience 24 (2), 168-175, 2021 | 1461 | 2021 |
| Hosts and sources of endemic human coronaviruses VM Corman, D Muth, D Niemeyer, C Drosten Advances in virus research 100, 163-188, 2018 | 1385 | 2018 |
| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23, 2020 | 1362 | 2020 |
| Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome T Kuiken, RAM Fouchier, M Schutten, GF Rimmelzwaan, ... The Lancet 362 (9380), 263-270, 2003 | 1329 | 2003 |
| SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 J Braun, L Loyal, M Frentsch, D Wendisch, P Georg, F Kurth, ... Nature 587 (7833), 270-274, 2020 | 1276 | 2020 |
| Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response I Glowacka, S Bertram, MA Müller, P Allen, E Soilleux, S Pfefferle, I Steffen, ... Journal of virology 85 (9), 4122-4134, 2011 | 1276 | 2011 |
